EUVIMEDEUVIMED entdecken
Crossref

Biobanking rare gynaecological tumours – How harmonised is data collection?

Sharon O'Toole, Olga Tzortzatou, Sara Casati, James P Beirne, Charles Savona-Ventura, Miriam J Azzopardi, Rita Micallef, Jean Calleja-Agius, Bridget Ellul

European Journal of Surgical Oncology · 2025

DOI: 10.1016/j.ejso.2024.108784 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Surgical Oncology, 2025. Verfasst von Sharon O'Toole und 8 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Obstetrics and Gynaecology/Histopathology, Trinity College Dublin, Trinity St James's Cancer Institute, St James's Hospital, Dublin 8,…. Hauptthemen laut MEDLINE: Genital Neoplasms, Female, Rare Diseases, Biological Specimen Banks, Data Collection. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 18 Literaturangaben. Gefördert von: European Cooperation in Science and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: GYNOCARE, the European Network for Gynaecological Rare Cancer Research, set out to evaluate the current status of biobanks with access to rare gynaecological tumours, with a view to harmonising sample and data collection and associated consent, to facilitate collaborative cross-border research, enabling clinical trials and translational research. METHODS: Two digital surveys were formulated, one covering clinical and scientific parameters and one exploring ethical and regulatory issues around informed consent. RESULTS: Data were analysed for 20 common responses, from 7 European countries. Tissue was the main sample type biobanked with 63 % also banking blood. Documentation of clinical data, treatment regimens and classification systems varied. Eighty percent collected pathological information. Most biobanks were linked to medical records but only one fifth with national registries. The Information Sheet covered governance, benefits/risks, sharing (mainly for non-profit research), return of results and data protection safeguards. Only 37 % informed patients about sample and data storage, although about half stored samples for an indefinite time. Pseudonymisation and Data Protection Officer approval were the prime data safeguards. Less than half explained the difference between anonymisation and pseudonymisation. Broad consent was the norm (84 %) and 95 % granted the right to withdraw consent. Three countries have Biobank legislation. CONCLUSION: These surveys provide a snapshot of the current state of biobanks and highlight divergences in the consent process and data management. More work is needed to understand what parameters are being gathered across more EU countries and thus harmonise the sample and data collection processes to facilitate cross-border research.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Genital Neoplasms, FemaleRare DiseasesBiological Specimen BanksData CollectionTissue BanksHumansFemaleEuropeInformed ConsentRegistriesSurveys and QuestionnairesBiomedical Research

Stichwörter der Autor:innen

Biobanking rare gynaecological cancersClinical parametersEthical issuesInformation sheetInformed consent formLegal issues

Autor:innen und Institutionen

  • Departments of Obstetrics and Gynaecology/Histopathology, Trinity College Dublin, Trinity St James's Cancer Institute, St James's Hospital, Dublin 8, Ireland. Electronic address: shotoole@tcd.ie.
  • Legal Department, Biomedical Research Foundation of the Academy of Athens, Athens, Greece. Electronic address: otzortzatou@bioacademy.gr.
  • Ethics Committee, University of Milan Bicocca, Piazza Ateneo Nuovo 1, Milano, Italy; Istituto per l'Endocrinologia e l'Oncologia "Gaetano Salvatore" (IEOS), Consiglio Nazionale delle Ricerche (National Research Council)…
  • Department of Gynaecological Oncology, Trinity St James's Cancer Institute, St James's Hospital, Dublin, Ireland. Electronic address: jamesybeirne@hotmail.com.
  • Department of Obstetrics and Gynaecology, Faculty of Medicine and Surgery, University of Malta, Msida, Malta. Electronic address: charles.savona-ventura@um.edu.mt.
  • Directorate for Health Information and Research, Ministry for Health and Active Ageing, G'Mangia, Malta. Electronic address: miriam.j.azzopardi@gov.mt.

Förderung

  • European Cooperation in Science and Technology

Zitieren

APA

O'Toole, S., Tzortzatou, O., Casati, S., Beirne, J. P., Savona-Ventura, C., Azzopardi, M. J., Micallef, R., Calleja-Agius, J., & Ellul, B. (2025). Biobanking rare gynaecological tumours – How harmonised is data collection?. European Journal of Surgical Oncology. https://doi.org/10.1016/j.ejso.2024.108784

Vancouver

O'Toole S, Tzortzatou O, Casati S, Beirne JP, Savona-Ventura C, Azzopardi MJ, et al. Biobanking rare gynaecological tumours – How harmonised is data collection?. European Journal of Surgical Oncology. 2025. doi:10.1016/j.ejso.2024.108784

BibTeX
@article{OToole2025,
  author = {O'Toole, Sharon and Tzortzatou, Olga and Casati, Sara and Beirne, James P and Savona-Ventura, Charles and Azzopardi, Miriam J and Micallef, Rita and Calleja-Agius, Jean and Ellul, Bridget},
  title = {Biobanking rare gynaecological tumours – How harmonised is data collection?},
  journal = {European Journal of Surgical Oncology},
  year = {2025},
  doi = {10.1016/j.ejso.2024.108784}
}
Kostenlos starten →